PREDICTING THE RISK OF GRAVES DISEASE RELAPSE: COMMENTARY ON "THYROID PEROXIDASE ANTIBODY POSITIVITY IS ASSOCIATED WITH RELAPSE-FREE SURVIVAL FOLLOWING ANTITHYROID DRUG TREATMENT FOR GRAVES DISEASE"

被引：0
|
作者：
Gallo, D. [1 ]
Tanda, M. L. [1 ]
Piantanida, E. [1 ,2 ]
机构：
[1] Univ Insubria, Dept Med & Surg, Endocrine Unit, Viale Borri 57, I-21100 Varese, Italy
[2] ASST Sette Laghi, Viale Borri 57, I-21100 Varese, Italy
来源：
ENDOCRINE PRACTICE | 2020年 / 26卷 / 09期
关键词：
HYPERTHYROIDISM; THERAPY;
D O I：
10.4158/EP-2020-0230
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1039 / 1041
页数：3
相关论文
共 50 条
  • [1] THYROID PEROXIDASE ANTIBODY POSITIVITY IS ASSOCIATED WITH RELAPSE-FREE SURVIVAL FOLLOWING ANTITHYROID DRUG TREATMENT FOR GRAVES DISEASE
    Muir, Christopher A.
    Jones, Graham Rd
    Greenfield, Jerry R.
    Weissberger, Andrew
    Samaras, Katherine
    ENDOCRINE PRACTICE, 2020, 26 (09) : 1026 - 1030
  • [2] Predicting relapse of Graves' disease following treatment with antithyroid drugs
    Liu, Lin
    Lu, Hongwen
    Liu, Yang
    Liu, Changshan
    Xun, Chu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (04) : 1453 - 1458
  • [3] Usefulness of Measuring Thyroid Stimulating Antibody at the Time of Antithyroid Drug Withdrawal for Predicting Relapse of Graves Disease
    Kwon, Hyemi
    Kim, Won Gu
    Jang, Eun Kyung
    Kim, Mijin
    Park, Suyeon
    Jeon, Min Ji
    Kim, Tae Yong
    Ryu, Jin-Sook
    Shong, Young Kee
    Kim, Won Bae
    ENDOCRINOLOGY AND METABOLISM, 2016, 31 (02) : 300 - 310
  • [4] Commentary on " Remission in pediatric Graves' disease treated with antithyroid drug and the risk factors associated with relapse"
    Kim, Ji Hyun
    ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2022, 27 (04) : 245 - 246
  • [5] Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy
    Choi, Yun Mi
    Kwak, Mi Kyung
    Hong, Sang Mo
    Hong, Eun-Gyoung
    ENDOCRINOLOGY AND METABOLISM, 2019, 34 (03) : 268 - 274
  • [6] Predictive effect of antithyroid antibody for relapse of Graves' disease
    Yoshizawa, Kazuko
    Aso, Keiko
    Satoh, Mari
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [7] Risk Factors for the Relapse of Graves' Disease Following Withdrawal of Antithyroid Drugs
    Yazidi, Meriem
    Ben Othmane, Rym
    Ben Mansour, Nadia
    Oueslati, Ibtissem
    Chaker, Fatma
    Chihaoui, Melika
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2021, 25 (03) : 272 - 278
  • [8] Remission in pediatric Graves' disease treated with antithyroid drug and the risk factors associated with relapse
    Wong, Tsz Wai Catherine
    Wong, Man Yee Shirley
    ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2022, 27 (04) : 308 - 314
  • [9] Valuable predictive features of relapse of Graves' disease after antithyroid drug treatment
    Liu, Xingjun
    Shi, Bingyin
    Li, Hao
    ANNALES D ENDOCRINOLOGIE, 2015, 76 (06) : 679 - 683
  • [10] STUDIES ON THYROID INDICATORS DURING THE RELAPSE OF GRAVES-DISEASE FOLLOWING DISCONTINUATION OF ANTITHYROID DRUG-THERAPY
    AKIYAMA, H
    KOBAYASHI, I
    YAMAGUCHI, T
    SHODA, Y
    OHSHIMA, K
    MORI, M
    SHIMOMURA, Y
    KOBAYASHI, S
    THYROID 1988, 1988, 796 : 439 - 442
12345